Photodynamic Therapy of Superficial Nasal Planum Squamous Cell Carcinomas in Cats: 55 Cases

被引:28
作者
Bexfield, N. H. [1 ]
Stell, A. J. [2 ]
Gear, R. N. [1 ]
Dobson, J. M. [1 ]
机构
[1] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England
[2] Univ London Royal Vet Coll, London, England
关键词
5-aminolaevulinic acid; PDT; Photosensitizer; Skin tumor; Treatment;
D O I
10.1111/j.1939-1676.2008.0186.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Squamous cell carcinomas (SCCs) are common skin tumors in cats. We investigated photodynamic therapy (PDT) using the photosensitizing agent 5-aminolaevulinic acid (5-ALA) topically and a high-intensity red light source. Hypothesis: PDT is a safe and effective treatment for feline SCCs. Animals: Fifty-five client-owned cats with superficial nasal planum SCCs. Methods: Prospective, uncontrolled clinical trial. PDT was performed using topical 5-ALA and light of peak wavelength 635 nm. Adverse effects, response, and tumor control were evaluated. Results: 53/55 (96%) cats responded to therapy, and there was a complete response in 47/55 (85%). Six cats (11%) had a partial response. Of the 47 cats with complete response to a single treatment, 24 recurred (51%), with a median time to recurrence of 157 days (95% confidence interval, 109-205 days). Repeat PDT was performed in 22 cats, and at a median follow-up of 1,146 days, 23 (45%) cats were alive and disease free, 17 (33%) had to be euthanized due to tumor recurrence, and 11 (22%) were euthanized for other reasons. Only transient mild local adverse effects were observed after treatment. Conclusions and Clinical Importance: PDT using 5-ALA and a red light source was safe, well tolerated, and effective in the treatment of superficial nasal planum SCCs of cats and offers an alternative to conventional therapy. Although initial response rates were high, this treatment did not lead to a durable remission or cure in all cases.
引用
收藏
页码:1385 / 1389
页数:5
相关论文
共 39 条
[1]   Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity [J].
Akita, Y ;
Kozaki, K ;
Nakagawa, A ;
Saito, T ;
Ito, S ;
Tamada, Y ;
Fujiwara, S ;
Nishikawa, N ;
Uchida, K ;
Yoshikawa, K ;
Noguchi, T ;
Miyaishi, O ;
Shimozato, K ;
Saga, S ;
Matsumoto, Y .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (02) :472-480
[2]  
Buchholz J, 2007, J VET INTERN MED, V21, P770, DOI 10.1892/0891-6640(2007)21[770:PTOFCS]2.0.CO
[3]  
2
[4]   Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview [J].
Cappugi, P ;
Campolmi, P ;
Mavilia, L ;
Prignano, F ;
Rossi, R .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (05) :494-502
[5]   RESPONSE OF SQUAMOUS-CELL CARCINOMA OF THE NOSE OF THE CAT TO TREATMENT WITH X-RAYS [J].
CARLISLE, CH ;
GOULD, S .
VETERINARY RADIOLOGY, 1982, 23 (05) :186-192
[6]   Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources [J].
Clark, C ;
Bryden, A ;
Dawe, R ;
Moseley, H ;
Ferguson, J ;
Ibbotson, SH .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2003, 19 (03) :134-141
[7]   Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic [J].
de Groot, D. J. A. ;
de Vries, E. G. E. ;
Groen, H. J. M. ;
de Jong, S. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (01) :52-69
[8]  
Dorn R. C., 1976, Journal of the American Animal Hospital Association, V12, P307
[9]   Sensitivity of osteoblasts, fibroblasts, bone marrow cells, and to 5-aminolevulinic acid based photodynamic therapy [J].
Egli, Rainer J. ;
Schober, Martin ;
Hempfing, Axel ;
Ganz, Reinhold ;
Hofstetter, Willy ;
Leunig, Michael .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2007, 89 (2-3) :70-77
[10]   Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors [J].
Ferrario, A ;
Fisher, AM ;
Rucker, N ;
Gomer, CJ .
CANCER RESEARCH, 2005, 65 (20) :9473-9478